- Language
-
Englisch
- Identifier
-
1241183392
Contributor
Berg, Johanna
Weber, Zia
Fechler-Bitteti, Mona
Hocke, Andreas C.
Hippenstiel, Stefan
Elomaa, Laura
Weinhart, Marie
Kurreck, Jens
Weber, Zia
Fechler-Bitteti, Mona
Hocke, Andreas C.
Hippenstiel, Stefan
Elomaa, Laura
Weinhart, Marie
Kurreck, Jens
- DOI
-
10.14279/depositonce-12372
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:57 PM CET
Associated
- Berg, Johanna
- Weber, Zia
- Fechler-Bitteti, Mona
- Hocke, Andreas C.
- Hippenstiel, Stefan
- Elomaa, Laura
- Weinhart, Marie
- Kurreck, Jens
Other Objects (12)
Optimization of cell-laden bioinks for 3D bioprinting and efficient infection with influenza A virus
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies
Clean Bioprinting – Fabrication of 3D Organ Models Devoid of Animal Components
Evaluating the Suitability of 3D Bioprinted Samples for Experimental Radiotherapy: A Pilot Study
3D-bioprinted HepaRG cultures as a model for testing long term aflatoxin B1 toxicity in vitro
Quantification of Major Bacteria and Yeast Species in Kefir Consortia by Multiplex TaqMan qPCR
Bioprinted cancer model of neuroblastoma in a renal microenvironment as an efficiently applicable drug testing platform
Kinetic Analysis of the Hydrolysis of Pentose‐1‐phosphates through Apparent Nucleoside Phosphorolysis Equilibrium Shifts
Colorectal cancer patient-derived xenograft (PDX) models as platform for drug screening, molecular and response analysis
Characterization of the immunomodulation by the forkhead transcription factor FOXO3
Optimizing human Treg stability and target specificity for therapeutic applications
Analytical methods and thermodynamic frameworks for efficient biocatalytic nucleoside synthesis via nucleoside phosphorylases
Optimization of cell-laden bioinks for 3D bioprinting and efficient infection with influenza A virus
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies
Clean Bioprinting – Fabrication of 3D Organ Models Devoid of Animal Components
Evaluating the Suitability of 3D Bioprinted Samples for Experimental Radiotherapy: A Pilot Study
3D-bioprinted HepaRG cultures as a model for testing long term aflatoxin B1 toxicity in vitro
Quantification of Major Bacteria and Yeast Species in Kefir Consortia by Multiplex TaqMan qPCR
Bioprinted cancer model of neuroblastoma in a renal microenvironment as an efficiently applicable drug testing platform
Kinetic Analysis of the Hydrolysis of Pentose‐1‐phosphates through Apparent Nucleoside Phosphorolysis Equilibrium Shifts
Colorectal cancer patient-derived xenograft (PDX) models as platform for drug screening, molecular and response analysis
Characterization of the immunomodulation by the forkhead transcription factor FOXO3
Optimizing human Treg stability and target specificity for therapeutic applications
Analytical methods and thermodynamic frameworks for efficient biocatalytic nucleoside synthesis via nucleoside phosphorylases
Optimization of cell-laden bioinks for 3D bioprinting and efficient infection with influenza A virus
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies
Clean Bioprinting – Fabrication of 3D Organ Models Devoid of Animal Components
Evaluating the Suitability of 3D Bioprinted Samples for Experimental Radiotherapy: A Pilot Study
3D-bioprinted HepaRG cultures as a model for testing long term aflatoxin B1 toxicity in vitro
Quantification of Major Bacteria and Yeast Species in Kefir Consortia by Multiplex TaqMan qPCR
Bioprinted cancer model of neuroblastoma in a renal microenvironment as an efficiently applicable drug testing platform
Kinetic Analysis of the Hydrolysis of Pentose‐1‐phosphates through Apparent Nucleoside Phosphorolysis Equilibrium Shifts
Colorectal cancer patient-derived xenograft (PDX) models as platform for drug screening, molecular and response analysis
Characterization of the immunomodulation by the forkhead transcription factor FOXO3
Optimizing human Treg stability and target specificity for therapeutic applications